Do you remember when you joined #X? I do!
Been 14 years in this space (from Twitter times) 😊 & it is always been exciting sharing science, education and ideas. The best part has been I have met amazing global community of scientists & educators along the way.
#MyXAnniversary
Some talks never get old(er), but we do age 😎. 5 years ago a talk on #Aging and metabolic diseases by @MoriLabe at our institute. It was pleasure hosting this internationsl seminar.
5 years ago I visited remote schools & guided students on their career paths. At that time #AI was just emerging but to me it was already clear it would transform everything. #DataScience and #biotech still hold strong.
Always happy and excited to guide young minds.
Came across this note from 5 years ago after supervising my first Master’s thesis. The student wrote this kind message.
Still grateful for the trust & realization that mentorship is among academia’s most rewarding parts.
The joy of helping young researchers grow has never faded
We are glad to invite you to the next ExoZoom!
Wednesday, May 28, at 3:30 PM.
Muhammad Nawaz, Ph.D.
Senior Scientist, Salzburg University
Sign up at https://t.co/dA0cUWAo9P to receive the zoom link
Final keynote speaker at #ISEV2025 Jan Lotvall @janlotvall from Unversity of Gothenburg @goteborgsuni Sweden shares his key discoveries and the journey of extracellular vesicles: from discovery to therapeutics.
Great talk by Nicole Meisner Kober from @PLUS_1622 as plenary speaker at #ISEV2025:
Converging EVs, LNPs and lessons learnt from virus biology for ultimately developing oral RNA drugs. 🧬💊
#Extracellularvesicles
.
The first plenary at #ISEV2025. Nicole Meisner-Kober shares her journey from industry to academia. She relates how #RNA drugs went from naked to modified to encapsulated in lipid nanoparticles #LNPs, with some notable successes. Yet dose and toxicity issues can still be a problem. Are #ExtracellularVesicles the answer? @IsevOrg
Carlos Salomon @cfsalomo presents the challenges about EV biomarker discovery, validation and translation.
An interesting question
Are we designing study for publishing a paper?
Or
Designing for clinically relevant biomarkers?
#ISEV2025#extracellularvesicles#exosomes
Mario Gimona (from Salzburg) presents GMP guidelines and clinical translation of #extracellularvesicles.
Identity, purity, Quality control attributes, batch to batch variability, potency, safty and regulatory aspects. And facilities (clean room).... etc...
#ISEV2025
I’m excited to share our latest preprint on Targeted delivery of mRNA to the heart via extracellular vesicles or lipid nanoparticles.
It’s been a great journey, and I’m proud of what we’ve achieved.
https://t.co/aslJW6tUMa
.
#extracellularVesicles#LipidNanoparticles#mRNA
Supper excited to share that I have been awarded Sahlgrenska Academy's International starting grant as a foundation to start my own research group.
https://t.co/AlsEiVrPka.
.
#ExtracellularVesicles#RNAdelivery
Celebrating 10 years of my first ever review article,&that in @NatRevUrol🥳 with @KislingerThomas
Early studies on #EVs are a landmark, many mentioned in this review e.g from Raposo, Clotilde, @janlotvall, Rak, breakefield @EditBuzas, @EstherNolteHoen & so https://t.co/NYZ9OKeIG9